

Detection of Cervical Cancer Using lncRNA Expression Data and Detection of Possible Biomarkers with Bagged CART Machine Learning Method
Abstract
Keywords
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209–49.
Small Jr W, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–12.
Meng Y, Liang H, Hu J, Liu S, Hao X, Wong MSK, et al. PD-L1 expression correlates with tumor infiltrating lymphocytes and response to neoadjuvant chemotherapy in cervical cancer. Journal of Cancer. 2018;9(16):2938.
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. Journal of the National cancer institute. 2011;103(5):368–83.
Shen S, Zhang S, Liu P, Wang J, Du H. Potential role of microRNAs in the treatment and diagnosis of cervical cancer. Cancer genetics. 2020;248:25–30.
Network CGAR. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378.
Xiao F-Y, Xie F, Sui L. Diagnostic accuracy of colposcopically directed biopsy and loop electrosurgical excision procedure for cervical lesions. Reproductive and Developmental Medicine. 2018;2(03):137–41.
Wang Q, Zhu C-Y, Chen L-M, Gao S-J, Du M, Zhang H-W, et al. Clinical value of human papillomavirus E6/E7 mRNA testing in patients with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion. Reproductive and Developmental Medicine. 2018;2(03):157–61.
Della Corte L, Barra F, Foreste V, Giampaolino P, Evangelisti G, Ferrero S, et al. Advances in paclitaxel combinations for treating cervical cancer. Expert Opinion on Pharmacotherapy. 2020;21(6):663–77.
Uyar D, Rader J. Genomics of cervical cancer and the role of human papillomavirus pathobiology. Clinical chemistry. 2014;60(1):144–6.
Aalijahan H, Ghorbian S. Long non-coding RNAs and cervical cancer. Experimental and molecular pathology. 2019;106:7–16.
Wu Z-H, Wang X-L, Tang H-M, Jiang T, Chen J, Lu S, et al. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncology reports. 2014;32(1):395–402.
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G, et al. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochemistry and Cell Biology. 2018;96(1):38–43.
Chen X, Yan CC, Zhang X, You Z-H. Long non-coding RNAs and complex diseases: from experimental results to computational models. Briefings in bioinformatics. 2017;18(4):558–76.
Tan J, Li X, Zhang L, Du Z. Recent advances in machine learning methods for predicting LncRNA and disease associations. Frontiers in Cellular and Infection Microbiology. 2022;12:1071972.
Yan H, Zheng G, Qu J, Liu Y, Huang X, Zhang E, et al. Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis. Journal of cellular physiology. 2019;234(12):23785–97.
Liu S, Xu C, Zhang Y, Liu J, Yu B, Liu X, et al. Feature selection of gene expression data for cancer classification using double RBF-kernels. BMC bioinformatics. 2018;19(1):1–14.
Chandrashekar G, Sahin F. A survey on feature selection methods. Computers & Electrical Engineering. 2014;40(1):16–28.
Zhang HH, Lu W. Adaptive Lasso for Cox's proportional hazards model. Biometrika. 2007;94(3):691–703.
Timofeev R. Classification and regression trees (CART) theory and applications. Humboldt University, Berlin. 2004;54.
Sutton CD. Classification and regression trees, bagging, and boosting. Handbook of statistics. 2005;24:303–29.
Choubin B, Abdolshahnejad M, Moradi E, Querol X, Mosavi A, Shamshirband S, et al. Spatial hazard assessment of the PM10 using machine learning models in Barcelona, Spain. Science of The Total Environment. 2020;701:134474.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87–108.
Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: a review. The Australian & New Zealand journal of obstetrics & gynaecology. 2011;51(2):103–8.
Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, et al. Genome-wide association study of susceptibility loci for cervical cancer. Journal of the National Cancer Institute. 2013;105(9):624–33.
Kori M, Gov E, Arga KY. Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis. Omics : a journal of integrative biology. 2019;23(5):261–73.
Yang A, Farmer E, Wu T, Hung C-F. Perspectives for therapeutic HPV vaccine development. Journal of biomedical science. 2016;23(1):1–19.
Dasari S, Wudayagiri R, Valluru L. Cervical cancer: Biomarkers for diagnosis and treatment. Clinica chimica acta; international journal of clinical chemistry. 2015;445:7–11.
Li J, Li Y-X, Li Y-Y. Differential regulatory analysis based on coexpression network in cancer research. BioMed research international. 2016;2016.
Cao S, Liu W, Li F, Zhao W, Qin C. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. International journal of clinical and experimental pathology. 2014;7(10):6776.
Ji N, Wang Y, Bao G, Yan J, Ji S. LncRNA SNHG14 promotes the progression of cervical cancer by regulating miR-206/YWHAZ. Pathology-Research and Practice. 2019;215(4):668–75.
DOI: https://doi.org/10.37591/rrjocb.v12i1.3194
Refbacks
- There are currently no refbacks.